https://ipharmag.com/article/uniqure-amt130-huntingtons-gene-therapy-fda-filing iPharmag en 2026-09-03T02:43:02+00:00 UniQure Files for FDA Approval of a Gene Therapy for Huntington’s Disease https://ipharmag.com/article/thyme-care-125m-series-e-oncology-navigation iPharmag en 2026-09-03T02:43:02+00:00 Cancer-Navigation Startup Thyme Care Raises $125M at a $2B+ Valuation https://ipharmag.com/article/semaglutide-slows-aging-extends-lifespan-mice iPharmag en 2026-09-03T02:43:02+00:00 Semaglutide Extended Lifespan and Slowed Aging in Mice — Beyond Just Weight Loss https://ipharmag.com/article/pancreatic-duct-cells-beta-cells-diabetes-aldh3b2 iPharmag en 2026-09-03T02:43:02+00:00 Flipping One Gene Turned Human Pancreatic Cells Into Insulin Producers https://ipharmag.com/article/padn-pulmonary-artery-denervation-heart-failure iPharmag en 2026-09-03T02:43:02+00:00 A Catheter Procedure Halved Worsening in a Dangerous Heart-Failure Complication https://ipharmag.com/article/teva-tev408-il15-celiac-disease-phase-2a iPharmag en 2026-09-02T15:31:17+00:00 Teva’s Antibody Protected the Gut From Gluten in a Celiac Disease Trial https://ipharmag.com/article/roche-simcere-sim0660-tri-specific-b-cell-deal iPharmag en 2026-09-02T15:31:17+00:00 Roche Pays Up to $1.53B for Simcere’s Three-Armed Antibody Targeting Autoimmune Disease https://ipharmag.com/article/obesity-immune-cell-memory-epigenetic iPharmag en 2026-09-02T15:31:17+00:00 Obesity Leaves a Lasting ‘Memory’ in Immune Cells — Even After Weight Loss https://ipharmag.com/article/fall-vaccination-guidelines-flu-covid-rsv-2026 iPharmag en 2026-09-02T15:31:17+00:00 Major Medical Societies Issue Fall Vaccination Guidance for Flu, COVID and RSV https://ipharmag.com/article/biotak-score-takotsubo-broken-heart-syndrome-test iPharmag en 2026-09-02T15:31:17+00:00 A Blood Test Can Tell ‘Broken Heart Syndrome’ From a Real Heart Attack https://ipharmag.com/article/pharmaessentia-besremi-essential-thrombocythemia-fda-approval iPharmag en 2026-09-02T04:04:01+00:00 FDA Approves Besremi for Essential Thrombocythemia — the First New Treatment in Nearly 30 Years https://ipharmag.com/article/mit-single-cell-striatum-atlas-neurological-disorders iPharmag en 2026-09-02T04:04:01+00:00 A Cell-by-Cell Map of a Key Brain Region Reveals Which Neurons Disease Hits Hardest https://ipharmag.com/article/gsk-mrna-flu-vaccine-two-antigen-ha-na iPharmag en 2026-09-02T04:04:01+00:00 GSK Bets Two Targets Beat One in the Race for a Better mRNA Flu Vaccine https://ipharmag.com/article/florida-sues-pbms-express-scripts-prime-price-fixing iPharmag en 2026-09-02T04:04:01+00:00 Florida Sues Two Big Drug Middlemen, Alleging They Fixed Prices to Squeeze Pharmacies https://ipharmag.com/article/arrowhead-plozasiran-severe-hypertriglyceridemia-phase-3 iPharmag en 2026-09-02T04:04:01+00:00 Arrowhead’s RNA Drug Cut Triglycerides ~80% and Slashed Pancreatitis in Phase 3